A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 110.38
GOOG 626.91
MSFT 45.57
FB 92.07
BAC 15.38

Recently Added

MHK 188.97
HLS 37.84
LB 93.06
TERP 17.26
SUNE 8.27

Gaining Speed

AR 21.98
HLS 37.84
AM 19.64
MHK 188.97
LB 93.06

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More

Get Alerted When News Hits On This Stock - FREE!